期刊文献+

成人隐匿性自身免疫性糖尿病患者血清IL-10、TGF-β水平及其与胰岛β细胞功能的关系 被引量:1

Expressions of IL-10 and TGF-β and their relations with Islet beta cell function in adults with latent autoimmune diabetes
原文传递
导出
摘要 目的探讨成人隐匿性自身免疫性糖尿病(LADA)患者外周血细胞因子白介素-10(IL-10)、转化生长因子-β(TGF-β)水平变化及其与胰岛β细胞功能的关系。方法以双抗夹心ELISA法检测30例LADA(LADA组)、30例2型糖尿病(T2DM组)、30例正常对照(正常对照组)外周血血清中IL-10、TGF-β水平,同时应用HOMA公式计算胰岛素释放指数(HOMA-IS)。结果LADA组的IL-10水平低于T2DM组(P<0.05),高于正常对照组(P<0.05)。LADA组的TGF-β水平与T2DM组相比,差异无统计学意义(P>0.05)。IL-10水平与患者LnHOMA-IS成正相关(r=0.314,P=0.017)。结论LADA患者体内存在细胞免疫功能失衡,不能有效地维持自身的免疫耐受,可能是LADA患者胰岛β细胞功能损害的主要因素。 Objective To investigate changes and significance of IL-10 and TGF-β in the peripheral blood of latent autoimmune diabetes in adults(LADA)patients.Methods 30 LADA patients,30 type 2 diabetic(T2DM)patients and 30 volunteers were involved in this study.Levels of IL-10 and TGF-β in the peripheral blood were determined by ELISA.A homeostasis model assessment of insulin secretion(HOMA-IS)was used to estimate insulin function.Results IL-10 in the LADA group was lower than that in the T2DM group but was higher than that in the control group.TGF-βhad no significant difference between the LADA group and the T2DM group.IL-10 had a positive correlation with LnHOMA-IS(r=0.314,P=0.017).Conclusion Our results suggest that an imbalance of cell immunity exists in LADA patients,which can not maintain the autoimmune tolerance and promote the generation and development of LADA,and is the main reason for impaired islet beta cell functions in LADA patients.
出处 《山东大学学报(医学版)》 CAS 北大核心 2009年第10期15-18,共4页 Journal of Shandong University:Health Sciences
基金 山东省医药卫生科技发展计划项目(1999CA1CDB1)
关键词 成人 隐匿性自身免疫性糖尿病 白介素-10 转化生长因子-β Adult Latent autoimmune diabetes IL-10 Transforming growth factor beta
  • 相关文献

参考文献14

  • 1Eizirik D L, Colli M L, Orris F, et al. The role of inflamma- tion in insulitis and beta-cell loss in type 1 diabetes[J]. Nat Rev Endocrinol, 2009,5 (4) : 219-226.
  • 2周智广,伍汉文.成人隐匿性自身免疫性糖尿病的诊断与治疗[J].中华内分泌代谢杂志,1998,14(1):1-2. 被引量:98
  • 3Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self- tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains(CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune disease[J]. J Immu- nol, 1995, 155(1):1151-1164.
  • 4Chatila T A. Regulatory T cells: key players in tolerance and autoimmunity[J]. Endocrinol Metab Clin North Am, 2009, 38 (2) :265-272.
  • 5Mellanby R J, Thomas D C, Lamb J, et al. Role of regulatory T-cells in autoimmunity[J].Clin Sci(Lond), 2009, 116(8) : 639-649.
  • 6Soto Akira, Nakajima Hiroshi, Ikeda Kei, et al. CD4^+ CD25^+ T-cell development is regulated by at least 2 distinct mechanisms [J], Blood. 2002, 99(7):555-560.
  • 7Cong Y, Weaver C T, Lazenby A, et al. Bacterial-reactive T regulatory cells inhibit pathogenic immune response to the enteric flora[J]. J Immunol, 2002, 169(11):6112-6119.
  • 8Strober W, Kitam A, Fuss I, et al. Transforming growth factor (TGF)-β1-producing regulatory T cells induce smad-mediated interleutin 10 secretion that facilitates coordinated immune oregulatory activity and amelioration of TGF-β1-mediated Fibrosis [J]. J Exp Med, 2003, 198(8) : 1179-1188.
  • 9Tsiavou A, Hatziagelakt E, Chaidaroglou A, et al. TNF-α, TGF-β1, IL-10, IL-6, gene polymorphisms in latent autoimmune diabetes of adults (LADA) and type 2 diabetes melhtus [J]. J Clin Immunol, 2004, 24(6):591-599.
  • 10石昌红,管庆波,高聆,马春燕,崔彬,刘国立,赵家军.成人隐匿性自身免疫性糖尿病患者CD4^+CD25^+T细胞的变化研究[J].中国免疫学杂志,2006,22(8):771-774. 被引量:7

二级参考文献21

  • 1王建民,周智广,文建新,伍汉文,ThomasDyrberg.谷氨酸脱羧酶(GAD_(65))自身抗体的放射配体检测法[J].中国糖尿病杂志,1997,5(2):85-88. 被引量:21
  • 2Tuomi T, Groop LC, Zimmet PZ, et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes, 1993,42:359-362.
  • 3Torn C, Landin-Olsson M, Lernmark A, et al. Prognostic factors for the course of β cell function in autoimmune diabetes. J Clin Endocrinol Metab, 2000,85:4619-4623.
  • 4Gottsater A, Landin-Olsson M, Lernmark A, et al. Glutamate decarboxylase antibody level predicts rate of beta-cell decline in adult-onset diabetes. Diabetes Res Clin Pract, 1995,27:133-140.
  • 5Gardner SG, Gale EA, Williams AJ, et al. Progression to diabetes in relatives with islet autoantibdies. Is it inevitable? Diabetes Care, 1999,22:2049-2054.
  • 6Yu L, Gianani R, Eisenbarth GS. Quantitation of glutamic acid decarboxylase autoantibody levels in prospectively evaluated relatives of patients with type 1 diabetes. Diabetes, 1994,43:1229-1233.
  • 7Turner R, Stratton I, Horton V, et al. UKPDS25 autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet, 1997,350:1288-1293.
  • 8Li H, Isomaa B, Taskinen MR, et al. Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes. Diabetes Care, 2000,23:589-594.
  • 9Montana E, Fernandez-Castaner M, Rosel P, et al. Age, sex and ICA influence on beta-cell secretion during the first year after the diagnosis of type 1 diabetes mellitus. Diabete Metab, 1991,17:460-468.
  • 10Kobayashi T, Nakanishi K, Sugimoto T, et al. Maleness as risk factor for slowly progressive IDDM. Diabetes Care, 1989,12:7-11.

共引文献127

同被引文献9

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部